Logo image of BMEZ

BLACKROCK HLTH SCI TRM TR II (BMEZ) Stock Overview

USA - NYSE:BMEZ - US09260E1055

14.99 USD
+0.01 (+0.07%)
Last: 10/21/2025, 8:04:00 PM
14.95 USD
-0.04 (-0.27%)
After Hours: 10/14/2025, 8:04:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BMEZ. BMEZ was compared to 0 industry peers in the Unkown industry. While BMEZ seems to be doing ok healthwise, there are quite some concerns on its profitability. BMEZ is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BMEZ has reported negative net income.
In the past year BMEZ had a positive cash flow from operations.
In multiple years BMEZ reported negative net income over the last 5 years.
Of the past 5 years BMEZ 4 years had a positive operating cash flow.
BMEZ Yearly Net Income VS EBIT VS OCF VS FCFBMEZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 1B -1B -2B

1.2 Ratios

Industry RankSector Rank
ROA -7.06%
ROE -7.2%
ROIC 0.61%
ROA(3y)-9.24%
ROA(5y)-0.06%
ROE(3y)-9.36%
ROE(5y)0.02%
ROIC(3y)N/A
ROIC(5y)N/A
BMEZ Yearly ROA, ROE, ROICBMEZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

Industry RankSector Rank
OM 25.26%
PM (TTM) N/A
GM 31.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BMEZ Yearly Profit, Operating, Gross MarginsBMEZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 5K -5K 10K 15K

More info and screens

5

2. Health

2.1 Basic Checks

BMEZ has less shares outstanding than it did 1 year ago.
There is no outstanding debt for BMEZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BMEZ Yearly Shares OutstandingBMEZ Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BMEZ Yearly Total Debt VS Total AssetsBMEZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

An Altman-Z score of 29.39 indicates that BMEZ is not in any danger for bankruptcy at the moment.
There is no outstanding debt for BMEZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 29.39
ROIC/WACCN/A
WACCN/A
BMEZ Yearly LT Debt VS Equity VS FCFBMEZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 1B -1B 2B -2B 3B

2.3 Liquidity

BMEZ has a Current Ratio of 0.49. This is a bad value and indicates that BMEZ is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.49 indicates that BMEZ may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.49
Quick Ratio 0.49
BMEZ Yearly Current Assets VS Current LiabilitesBMEZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

3

3. Growth

3.1 Past

BMEZ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -381.82%.
BMEZ shows a strong growth in Revenue. In the last year, the Revenue has grown by 105.66%.
The Revenue has been growing by 66.80% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-381.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-457.14%
Revenue 1Y (TTM)105.66%
Revenue growth 3Y66.8%
Revenue growth 5YN/A
Sales Q2Q%-18.43%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BMEZ Yearly Revenue VS EstimatesBMEZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BMEZ. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BMEZ Price Earnings VS Forward Price EarningsBMEZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 1.11
EV/EBITDA N/A
BMEZ Per share dataBMEZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 12.32%, BMEZ is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.36, BMEZ pays a better dividend.
Industry RankSector Rank
Dividend Yield 12.32%

5.2 History

BMEZ has been paying a dividend for over 5 years, so it has already some track record.
BMEZ has decreased its dividend recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
BMEZ Yearly Dividends per shareBMEZ Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

BMEZ has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-295.65%
EPS Next 2YN/A
EPS Next 3YN/A
BMEZ Yearly Income VS Free CF VS DividendBMEZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 1B -1B -2B

More info and screens

BLACKROCK HLTH SCI TRM TR II

NYSE:BMEZ (10/21/2025, 8:04:00 PM)

After market: 14.95 -0.04 (-0.27%)

14.99

+0.01 (+0.07%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)09-04 2025-09-04
Earnings (Next)03-02 2026-03-02
Inst Owners16.07%
Inst Owner Change0.11%
Ins OwnersN/A
Ins Owner Change0%
Market Cap936.88M
Analysts0
Price TargetN/A
Short Float %0.09%
Short Ratio0.22
Dividend
Industry RankSector Rank
Dividend Yield 12.32%
Yearly Dividend1.71
Dividend Growth(5Y)N/A
DP-295.65%
Div Incr Years1
Div Non Decr Years1
Ex-Date10-15 2025-10-15 (0.11)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 31.56
P/FCF 1.11
P/OCF 1.11
P/B 0.98
P/tB 0.98
EV/EBITDA N/A
EPS(TTM)-1.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)13.5
FCFY90.09%
OCF(TTM)13.5
OCFY90.09%
SpS0.48
BVpS15.33
TBVpS15.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.06%
ROE -7.2%
ROCE 0.77%
ROIC 0.61%
ROICexc 0.61%
ROICexgc 0.61%
OM 25.26%
PM (TTM) N/A
GM 31.02%
FCFM 2842.71%
ROA(3y)-9.24%
ROA(5y)-0.06%
ROE(3y)-9.36%
ROE(5y)0.02%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.49
Quick Ratio 0.49
Altman-Z 29.39
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-381.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-457.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)105.66%
Revenue growth 3Y66.8%
Revenue growth 5YN/A
Sales Q2Q%-18.43%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y162.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y231.11%
FCF growth 3Y12.07%
FCF growth 5YN/A
OCF growth 1Y231.11%
OCF growth 3Y12.07%
OCF growth 5YN/A